Accelerating Excellence in Translational Science (AXIS)
Project Number5U54MD007598-15
Contact PI/Project LeaderVADGAMA, JAYDUTT V.
Awardee OrganizationCHARLES R. DREW UNIVERSITY OF MED & SCI
Description
Abstract Text
Abstract: Proposed Program Overview. The Charles R. Drew University of Medicine and Science proposes
to continue the enhancement and success of the Accelerating Excellence in Translational Science (AXIS)
Center. AXIS has shown to be the integrated hub for research conducted at CDU and continues to provide
experienced leadership, and a myriad of clinical, translational, and community partnered activities. In the next
five years, research will continue to grow and expand its enterprise alongside the Universities vision and mission
to be a leader in eliminating health disparities by translating scientific discoveries into education, training, clinical
care, treatment, and community service in three areas of focus which disproportionally affect Service Planning
Area 6: Cancer, Cardiometabolic Disease (CMD), and HIV/AIDS. In addition, we look to build upon the
application of Precision Medicine to understand and eliminate health disparities, while utilizing many of CDU’s
outstanding resources in: Advanced Technologies such as Next Generation Sequencing for identifying Genomic
Data; Drug Discovery; Integrated Clinical Tissues, Biorepository and Bio banking Facility; Clinical Studies/Trials
Resources; Medical Bioinformatics; and Methods for Statistical and Epidemiological Studies. This approach will
pave the pathway for CDU’s in becoming a competitive institution with sophisticated resources and services to
better serve our communities. To accomplish this, we propose to continue with the three programmatic goals
that align with the mission, vision, and strategic plan for the universities research enterprise:
Goal 1: To enhance the infrastructure capacity in translational research using Precision Medicine model in the
areas of Cancer, Cardiometabolic, and HIV/AIDS. Provide support for the emerging research pillars in Mental
Health and Health Services
Goal 2: To continue the integration of basic, clinical, behavioral and community-partnered research by fostering
collaboration among disciplines, departments and schools at CDU, and sustainable collaboration with community
leaders and investigators across other research institutions.
Goal 3: To facilitate and elevate professional development and best practices in mentored clinical and
translational research training on minority health and health disparities.
Public Health Relevance Statement
PUBLIC HEALTH RELEVANCE: The predominant ethnic and racial demographics of residents in South Los
Angeles, Service Planning Area 6 is Hispanic/Latino (68%) and African American (27%). These communities
reside in one of the most underserved and under-resourced location, where access to health care and socio-
economic standards are lower than any other county in Los Angeles and in the US. As a result, these
communities are more often diagnosed with chronic conditions associated with Obesity, Diabetes, Hypertension,
Infectious Diseases, and Mental Health. The incidence, morbidity and mortality rates are highest from Cancer,
Cardiovascular Diseases, and Infectious Diseases. Our proposed study will focus on understanding how these
socio-economic and environmental factors impact cellular, molecular, genetic, and epigenetic drivers that cause
poor health outcomes in our communities. Our study will provide opportunities for interventions to reduce health
disparities.
NIH Spending Category
No NIH Spending Category available.
Project Terms
AccelerationAffectAfrican AmericanAreaBehavioralBioinformaticsCardiometabolic DiseaseCardiovascular DiseasesCenter for Translational Science ActivitiesChronicClinicalClinical ResearchClinical ServicesCollaborationsCommunicable DiseasesCommunitiesCommunity ServicesCountyDevelopmentDiabetes MellitusDiagnosisDisciplineEducationEnvironmental Risk FactorEpigenetic ProcessEthnic OriginFosteringGeneticGoalsHIV/AIDSHealth ServicesHispanicHypertensionIncidenceInfrastructureInstitutionInterventionLatinoLeadershipLocationLos AngelesMalignant NeoplasmsMedicalMedicineMental HealthMentorsMissionModelingMolecularMorbidity - disease rateObesityPathway interactionsRaceReduce health disparitiesResearchResearch PersonnelResearch TrainingResourcesSchoolsScienceServicesSocioeconomic FactorsStatistical MethodsStatistical StudyStrategic PlanningTechnologyTissuesTrainingTranslatingTranslational ResearchUniversitiesbiobankcardiometabolismcare systemsdemographicsdrug discoveryepidemiology studyexperiencegenomic datahealth care availabilityhealth disparityminority healthminority health disparitymortalitynext generation sequencingpoor health outcomeprecision medicineprogramspublic health relevancesocioeconomicssuccesstreatment services
National Institute on Minority Health and Health Disparities
CFDA Code
307
DUNS Number
785877408
UEI
PFBDNBDS57H3
Project Start Date
28-September-2009
Project End Date
14-August-2024
Budget Start Date
01-March-2023
Budget End Date
14-August-2024
Project Funding Information for 2023
Total Funding
$3,907,027
Direct Costs
$2,831,980
Indirect Costs
$1,075,047
Year
Funding IC
FY Total Cost by IC
2023
National Institute on Drug Abuse
$71,750
2023
National Institute on Minority Health and Health Disparities
$3,835,277
Year
Funding IC
FY Total Cost by IC
Sub Projects
No Sub Projects information available for 5U54MD007598-15
Publications
Publications are associated with projects, but cannot be identified with any particular year of the project or fiscal year of funding. This is due to the continuous and cumulative nature of knowledge generation across the life of a project and the sometimes long and variable publishing timeline. Similarly, for multi-component projects, publications are associated with the parent core project and not with individual sub-projects.
No Publications available for 5U54MD007598-15
Patents
No Patents information available for 5U54MD007598-15
Outcomes
The Project Outcomes shown here are displayed verbatim as submitted by the Principal Investigator (PI) for this award. Any opinions, findings, and conclusions or recommendations expressed are those of the PI and do not necessarily reflect the views of the National Institutes of Health. NIH has not endorsed the content below.
No Outcomes available for 5U54MD007598-15
Clinical Studies
No Clinical Studies information available for 5U54MD007598-15
News and More
Related News Releases
No news release information available for 5U54MD007598-15
History
No Historical information available for 5U54MD007598-15
Similar Projects
No Similar Projects information available for 5U54MD007598-15